Stryker Q2 sales jump 9.9%: 5 things to know

Laura Dyrda -   Print  |

Stryker reported an increase in overall sales, driven by a 3.7 percent jump in orthopedics sales during the second quarter.

Five things to know:

1. Stryker reported net sales increased 9.9 percent to $3.7 billion. Orthopedics sales were up 3.7 percent to $1.3 billion while spine and nanotechnology jumped 18.9 percent to $800 million. For the six months end, overall sales were up 9.2 percent to $7.1 billion

2. Net earnings hit $480 million for the quarter, up 6.2 percent compared to the same period last year.

3. U.S. sales for the second quarter were up 13 percent overall, hitting $2.7 billion. International sales were up slightly, 1.9 percent, to $955 million.

4. Knee sales were up 4.2 percent to $440 million while hip sales grew just 1.9 percent to $343 million. Trauma and extremities sales were up 2 percent to $394 million and spine sales increased 37.5 percent to $277 million, post-K2M acquisition.

5. Stryker expects full year organic net sales to increase 7.5 percent to 8 percent. Projected adjusted net earnings per share are $8.15 to $8.25 for the full year.

More articles on orthopedic devices:
Life Spine receives FDA clearance for expandable spacer implant
Medtronic, Alphatec & more: 7 device company notes
15 spine devices receive FDA 510(k) clearance in June


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers